Chen et al. characterized BRAF(ΔLNVTAP) that resembles BRAF(ΔNVTAPT) in cancer genomes, and found that its activity was blocked by the central R509H alteration in dimer interface [32]. This evidence concerns the gene BRAF and cancer.